Stocktoria

CORCEPT THERAPEUTICS INC CORT

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2004-04-15 · LEI

CORCEPT THERAPEUTICS INC statistics & valuation

Market cap$9.4B
P / E94.1×
P / S12.3×
P / B14.5×
P / FCF66.1×
Net margin13.1%
Return on equity15.4%
FCF margin18.6%
Return on capital6.7%
Graham number -91.1%$9.98

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports. The Graham number is Benjamin Graham's rough maximum fair value ($9.98); a green figure means the price is below it.

Profitability & efficiency

Net margin (%)
10.00% 81.10% 30.00% 30.70% 30.00% 30.70% 25.20% 22.00% 20.90% 13.10% 2016201720182019202020212022202320242025
Gross margin (%)
2016201720182019202020212022202320242025
Operating margin (%)
12.50% 33.20% 35.60% 36.40% 36.20% 34.00% 28.00% 22.20% 20.30% 5.90% 2016201720182019202020212022202320242025
Return on equity (%)
19.70% 67.60% 27.30% 25.40% 20.30% 29.90% 20.20% 20.90% 20.80% 15.40% 2016201720182019202020212022202320242025
Shares outstanding
116.1M 124.5M 126.7M 122.6M 124.2M 126.0M 116.0M 111.7M 113.5M 120.0M 2016201720182019202020212022202320242025
Net debt ($)
-$51.5M -$31.1M 2016201720182019202020212022202320242025
Share buybacks ($)
2016201720182019202020212022202320242025
Return on assets (%)
11.80% 58.50% 24.20% 22.80% 18.50% 26.60% 17.40% 17.10% 16.80% 11.90% 2016201720182019202020212022202320242025
Free cash flow margin (%)
22.40% 38.00% 45.90% 44.10% 42.60% 45.70% 29.80% 26.20% 29.10% 18.60% 2016201720182019202020212022202320242025
Debt / equity (×)
0.00× 0.00× 2016201720182019202020212022202320242025
EPS ($)
$0.07 $1.04 $0.60 $0.77 $0.85 $0.89 $0.87 $0.94 $1.23 $0.82 2016201720182019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

P / E vs its own history

CORCEPT THERAPEUTICS INC trades at about 136.8× earnings — above its 10-year norm (10-year range 16.5×–101.6×, median 26.3×).

16.5× 136.8×

Shaded band = 10-year range (16.5×–101.6×); dot = today's 136.8×.

Historical P/E = month-end price near each fiscal year-end ÷ that year's EPS. A read on whether the stock is cheap or dear relative to how it has typically been valued — not a forecast.

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Operating margin5.9%20.3%22.2%28.0%34.0%36.2%36.4%35.6%33.2%12.5%
Net margin13.1%20.9%22.0%25.2%30.7%30.0%30.7%30.0%81.1%10.0%
FCF margin18.6%29.1%26.2%29.8%45.7%42.6%44.1%45.9%38.0%22.4%
Return on assets11.9%16.8%17.1%17.4%26.6%18.5%22.8%24.2%58.5%11.8%
Return on equity15.4%20.8%20.9%20.2%29.9%20.3%25.4%27.3%67.6%19.7%
Debt / equity————————0.00×0.00×
Current ratio2.923.354.396.895.6010.077.916.664.202.40

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.